MedPath

SANDOZ LEVOBUNOLOL

SANDOZ LEVOBUNOLOL

Discontinued
DIN Number

02241715

Drug Class

Human

Market Date

Aug 21, 2000

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02241715
AIG Number0116868002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01ED03 LEVOBUNOLOL
Product Specifications
Dosage FormLiquid
Route of AdministrationOphthalmic
AHFS Classification52:40.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

LEVOBUNOLOL HYDROCHLORIDEActive
Strength: 0.25 %
Monograph: LEVOBUNOLOL HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.